Yttrium-90 Radioembolization of Metastatic Adrenocortical Carcinoma to the Liver following Systemic Chemotherapy and Surgical Resection of the Primary Lesion
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Yttrium-90 Radioembolization of Metastatic Adrenocortical Carcinoma to the Liver following Systemic Chemotherapy and Surgical Resection of the Primary Lesion ; volume:13 ; number:1 ; year:2020 ; pages:158-163
Case reports in oncology ; 13, Heft 1 (2020), 158-163
- Creator
-
Pigg, Nicholas
Aboubechara, Daniel
Fourzali, Roberto
Baigorri, Brian
- DOI
-
10.1159/000504779
- URN
-
urn:nbn:de:101:1-2020051400511403924807
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pigg, Nicholas
- Aboubechara, Daniel
- Fourzali, Roberto
- Baigorri, Brian
Other Objects (12)
Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology
Planning Arteriography for Yttrium-90 Microsphere Radioembolization
Gastroduodenal ulceration following liver radioembolization with yttrium-90
Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
Segmental Yttrium-90 Radioembolization as an Initial Treatment for Solitary Unresectable HCC
Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres
The value of yttrium-90 PET/CT after hepatic radioembolization: a pictorial essay
Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization
Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres
Survival Benefit of Aggressive Treatment Approaches Incorporating Yttrium-90 Radioembolization for Late-Stage Hepatocellular Carcinoma
Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology
Planning Arteriography for Yttrium-90 Microsphere Radioembolization
Gastroduodenal ulceration following liver radioembolization with yttrium-90
Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
Segmental Yttrium-90 Radioembolization as an Initial Treatment for Solitary Unresectable HCC
Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres
The value of yttrium-90 PET/CT after hepatic radioembolization: a pictorial essay
Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization
Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres
Survival Benefit of Aggressive Treatment Approaches Incorporating Yttrium-90 Radioembolization for Late-Stage Hepatocellular Carcinoma
Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology
Planning Arteriography for Yttrium-90 Microsphere Radioembolization
Gastroduodenal ulceration following liver radioembolization with yttrium-90
Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
Segmental Yttrium-90 Radioembolization as an Initial Treatment for Solitary Unresectable HCC
Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres
The value of yttrium-90 PET/CT after hepatic radioembolization: a pictorial essay
Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization
Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres